Peer Review History
| Original SubmissionSeptember 25, 2023 |
|---|
|
PONE-D-23-30430Fetal and Neonatal Echocardiographic Analysis of Biomechanical Alterations for the Hypoplastic Left HeartPLOS ONE Dear Dr. Vlachos, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 17 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hany Mahmoud Abo-Haded, MD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data). 3. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 4. In this instance it seems there may be acceptable restrictions in place that prevent the public sharing of your minimal data. However, in line with our goal of ensuring long-term data availability to all interested researchers, PLOS’ Data Policy states that authors cannot be the sole named individuals responsible for ensuring data access (http://journals.plos.org/plosone/s/data-availability#loc-acceptable-data-sharing-methods). Data requests to a non-author institutional point of contact, such as a data access or ethics committee, helps guarantee long term stability and availability of data. Providing interested researchers with a durable point of contact ensures data will be accessible even if an author changes email addresses, institutions, or becomes unavailable to answer requests. Before we proceed with your manuscript, please also provide non-author contact information (phone/email/hyperlink) for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If no institutional body is available to respond to requests for your minimal data, please consider if there any institutional representatives who did not collaborate in the study, and are not listed as authors on the manuscript, who would be able to hold the data and respond to external requests for data access? If so, please provide their contact information (i.e., email address). Please also provide details on how you will ensure persistent or long-term data storage and availability. Additional Editor Comments: This is a small study exploring the biomechanics of the single right ventricle during perinatal transition, particularly focussing on novel measures. In my opinion, this study needs to be reframed as a technical paper. The study is too small and the variety of patient anatomy too great to “understand the fetal and neonatal SRV..” as stated in the abstract. I think if reframed, this could be an interesting and useful technical paper. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I congratulate with authors for their novel type of echocardiography examination. The manuscript is well written in each section and well structured with appropriate attention for style! As an Obstetrician involved in prenatal ultrasound diagnosis I dont have the appropriate background to evaluate the mathematics calculation behind the formulas. Images and Table are of high quality. Reviewer #2: Thank you for providing the opportunity to review the paper titled 'Fetal and Neonatal Echocardiographic Analysis of Biomechanical Alterations for the Systemic Right Ventricle Heart.' In this paper, the authors reported on changes in diastolic function of the SRV using a novel ultrasonographic method during both the prenatal and postnatal periods. The manuscript was well-written, and I have no concerns regarding this paper. Reviewer #3: Title: Fetal and Neonatal Echocardiographic Analysis of Biomechanical Alterations for the Hypoplastic Left Heart PONE-D-23-30430 This is a small study exploring the biomechanics of the single right ventricle during perinatal transition, particularly focussing on novel measures. In my opinion, this study needs to be reframed as a technical paper. The study is too small and the variety of patient anatomy too great to “understand the fetal and neonatal SRV..” as stated in the abstract. I think if reframed, this could be an interesting and useful technical paper. Abstract The background could better reflect the study. The objective of the study seems to be to compare standard echo measures to novel measures using a range of SRV case types. In my opinion, the study is largely a technical paper about use of novel biomechanical measures in a small group of patients. Introduction The introduction lacks cohesion and after reading it, I was still not clear what this study was about. It does not address a) perinatal transition or b) neonatal hemodynamics of the SRV. I would encourage the authors to clarify what the study is really about: that hemodynamic changes in the SRV during perinatal transition are poorly understood, and that current measures may insufficiently capture systolic and diastolic function. Then, the aims of the study are to compare novel and standard measures to better describe perinatal changes. Line 66 – 70 discuss benefits of fetal detection and that pediatric echo is used to treat. Whilst true, these statements aren’t really relevant to the paper. Line 71 – remove “i.e.”. SV and CO are not the only measures of systolic function and are not routinely reported in most centres. It would be better to say “e.g.” and quote measures more commonly used, such as RVFAC, TAPSE, TDI S’. Line 77 – what do the authors mean by “hemodynamics” here? This is too vague; I am genuinely uncertain what they are referring to, and the reference is to an overall guideline from 2004. As an aside, there are several more recent AHA / JASE guidelines on Fetal Echo – the Donofrio 2014 one is quoted. Moon-Grady 2023 should also be quoted: https://doi.org/10.1016/j.echo.2023.04.014. Line 79 – 82: I think this paragraph needs rewording. Software does not rely on automated segmentation to work, as the workflow is to manually trace the chambers. Perhaps “rely” is not the correct word? The discussion regarding segmentation is unclear, and not well referenced – only to overall guidelines. Do they mean segmentation of the image into an LV / RV for example? I think this is what they mean, and if better defined, it will help to clarify the other points. This is indeed manual. Or segmentation of the ventricles? This is done automatically by software (Tomtec, EchoPac, Syngo). Strain is not difficult to obtain, for example, a global longitudinal strain measurement on a fetal study. Strain does not “rely” on ventricular segmentation to my knowledge, although of course it relies on segmentation of the image (identification of the ventricle). This is a somewhat superficial point in a paper which is not really about automatically finding parts of the image (e.g. through an AI algorithm). The authors approach also relies upon manual identification of the annulus and apex. It is true that dividing the ventricle, particularly a SRV, into, for example, a six-segment model, is difficult, and whether the septum should be included or not (as it constitutes a variable amount of wall) in a HLHS fetus / infant is unclear. Methods The methodology is largely a detailed mathematical description of analysis. This is beyond my ability to review critically. It is unclear what frame rates the images were taken at or stored at. Given the rest of the analysis is likely frame-rate dependent, and the high heart rates in fetuses and neonates, this should be quoted. Line 112: I believe the machine was an SC2000 – there is a zero missing. The authors state that automated speckle tracking of the mitral annulus has been previously validated. Indeed, speckle tracking includes the annulus in general. However, as the authors spell out at length the process for tracking the annulus, is the algorithm new in some way? If so, how has it been validated? If not different from standard speckle tracking, what is new? The peak annulus velocities in standard TDI differ from this process, as no tracking is performed – it is derived from movement of the annulus THROUGH a static pulse-wave sector. Therefore, the normal values are likely different. Is there prior data defining a normal range in fetuses and newborns, and how it compares to standard TDI? The reference [21] refer to accuracy using adult validation – much lower heart rates. You cannot extrapolate. The reference [25, 2020] for vortices seems to be theoretical and small animal models. It there a follow-up in humans? What would be considered the gold standard? It seems that the authors have moved strait to assessing pathology using this method. Line 149: what limitations are the authors referring to – this is not clear. Line 151: GLSr is not defined at first use, and not a standard abbreviation. Line 184: There is a sentence fragment. Line 188: Segmentation using Simpson’s rule – do the authors mean calculation of volume based on length and cross-sectional ellipses? Perhaps this needs to referenced (if one exists) as accurate for a single right ventricle, which is not conical? No explanation on how the SV / CO, or many of the other standard echo measures were obtained is reported. These can be done using geometric assumptions or the continuity equation. This should be specified. Results Restrictive patent foramen ovale is not a subtype of SRV – this needs clarification. Surely, as the authors have the images, the subtype should be able to be reported on all the studies – one is not. Two of the patients have L-looped ventricles, one cardiogenetic shock as a complication, one total anomalous veins and one moderate TR! This is a highly heterogenous group hemodynamically. I don’t think you can put them all together and draw any conclusions about the SRV. This loops back to the paper being largely technical – the differences in data that are obtained from the novel methodologies may be useful, even in a heterogenous group. If the authors disagree, further anatomical description / explanation to justify this is required. In reporting, more clarity on which results (fetal vs newborn) are being reported is needed. The authors reference and interpret diastolic parameters using guidelines which, to my knowledge, are not validated, and have evidence that they do not necessarily reflect dysfunction in either fetuses, neonates or SRV. I recommend that they refrain from interpretation, and just describe the parameters they evaluated. Ref 20 is not the most recent and is focussed on adults. Do the authors have any data on correlation between measures such as IVPD and E/e’? Discussion Lines 292 – 319 is largely data that is already known about the SRV using standard echo techniques and could be more efficiently discussed. The discussion of diastolic function is logically flawed – the authors first note that “conventional imaging measures do not correlate with diastolic function”, but then use the same measures to make conclusions, for example, that the filling pressures are elevated. The E/e’ in a fetus / neonate with altered filling conditions and afterload may not mean the same thing as in an adult or even a normal neonate. Again, the reference is to a document focussed on adults. And not for the right ventricle. The evidence quoted from Line 328 is fairly weak – the MPI is not a strong measure of DD. More reliance on atrial contraction can be due to higher volume requirements. Without a measure of wall stress / filling pressures, the impact on the ventricular muscle in terms of pathways leading to fibrosis are unknown. Line 315 319: The phases of inflow are explained as due to exposure to systemic and pulmonary pressure. This is likely not the reason and requires clarification. The SRV in utero is exposed to higher diastolic volume loading and required to produce higher cardiac output. The preload will depend on the compliance of the ventricle (it may be able to maintain low EDP), and the afterload on systolic function, placental function and SVR. The pulmonary pressures should not influence these parameters, and should not influence the relative phases of filling. Filling further increases after birth with falling PVR, so 318 – 319 is likely true. Line 340 - Should this be in the limitations section? While it’s unclear what the “above methods” refers to, if the authors refer to the methods they used in this study, I agree that they are not directly applicable without better validation. These techniques need direct correlations with gold standard measures such as invasive animal models or cath lab Ees measures of function before we can draw conclusions. If this data in fact exists, this needs to be elucidated in the discussion and methods. Limitations: The study is retrospective, with small numbers. The fetal studies were quite early (33 weeks), which means they may not be representative of biomechanics immediately prior to birth. Reviewer #4: The manuscript entitled "Fetal and Neonatal Echocardiographic Analysis of Biomechanical Alterations for the Hypoplastic Left Heart" uses a novel imaging algorithm to quantify measurements of fetal and neonatal echocardiography in healthy and SRV hearts. The data show not only early diastolic dysfunction in SRV hears compared to healthy controls, but also some subtle differences in systolic function during the neonatal period. While the image analysis is intricately detailed in the methods, this imaging algorithm to my knowledge is an n=1. One question that I have, is the imaging algorithm used in Matlab for this analysis available on github or some other public forum for other users. This is important as the measurements detailed herein would only be acquired by the sites involved in this particular study and would not be generalizable to a broader user, in particular neonatologists and pediatric cardiologists in a clinical setting. One of the major concerns in this manuscript is that the data acquired from this algorithm is not compared to any other clinical measurement for the purpose of validation and there is no way to assess whether these measurements are of clinical quality or not. Given that this was a retrospective study, it would seem reasonable that these echoes would have been quantified by health care practitioners and would likely have this data stored in the electronic medical records as a way to compare the algorithm measures of standard measurements such as E, A, E/e', etc.. as a way to compare those standard measurements against the algorithm. Without some way of comparing the algorithm to a gold standard we are only left to assume these measurements are valid. If possible, can the authors provide some comparisons between standard software derived measures against the algorithm. Also, from the statistical analysis the authors used a students t-test to compare differences between groups in this analysis. Since you used a parametric analysis, why weren't the reported values as mean (SD)? Was your data normally distributed and did the authors perform a normality test prior to the use of a parametric test. The authors reported median (IQR) which is fine but usually these values are reported when using non-parametric tests like the Wilcoxon. Below I have some minor comments: 1) Line 185: There is a sentence that consists of "This." I presume that is a typo, please remove. 2) Line 205: the prhase "to under differences in filling", I presume you meant understand differences in filling 3) Line 236: The authors say that SV is increased compared to control LV and RV in the prenatal setting but the statistics would suggest that SV in SRV is increased compared to the LV and trending in the RV (p=0.06) 4) Line 275: I believe the reference was to the E/A ratio but in the sentence, it says E/, please fix this for clarity 5) Line 287: "Stronger EL was observed both diastole", might want to add the during after observed 6) Line 311: The median E/e' in SRV group during postnatal was listed as 1.57, which is a typo based on the table showing 15.7. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Katsusuke Ozawa Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-30430R1Fetal and Neonatal Echocardiographic Analysis of Biomechanical Alterations for the Hypoplastic Left HeartPLOS ONE Dear Dr. Vlachos, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Academic Editor response to authors: The authors are possibly trying to answer the wrong question or using the wrong comparisons to answer it. We dont really know what predestines some systemic RVs to fail while others do well, and I suspect that is what is behind a study like this where standard echo oarameters are not sensitive enough... But I think this study may have within it the data which may start to unravel this... The fetal systemic RV is doing much the same job as it is postnatally (in a 'single ventricle' circulation, whereas there are much larger changes in the loading on the systemic LV (or indeed the subpumonary RV) in the biventricular circualation. THus using the normal hearts as controls is counterintuitive at least to me. To me the 'money' is in the changes from pre to postnatal parameters on the same ventricle, +/- the same ventricle in a biventriclar ciurculation eg ccTGA, or indeed TGA pre repair. Comparing the CHANGES to the changes for the biventricular LV may also be of interest but there are much greater differences in the loading conditions in this especially depending on timing of ductal closure as well as the timing of the drop in PVR.. which varies per individual. So I think possibly reanalysing these data in a different way would be of more physiologic interest. I realy dont thing comparing absolue measurements of any of these parameters between different ventrciular morpholgies makes much sense as intrinsically they are not only constructed differently at the cellular and fibromuscular architecture level but they have different shapes, different loading conditions and even different interventricular interactions depending on the status of the other ventricle So to me this study demonstrates some novel techniques but the questions as to their utility remain, to me as yet, completely unaddressed. Maybe I have missed the point but I dont think this is publishable without some reference to this. ============================== Please submit your revised manuscript by Jul 18 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hany Mahmoud Abo-Haded, MD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #5: (No Response) Reviewer #6: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #5: Partly Reviewer #6: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #5: I Don't Know Reviewer #6: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #5: Yes Reviewer #6: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #5: Yes Reviewer #6: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #5: The authors compared echocardiograhpy-derived biomehcanic data of 10 systemic right ventricels subjects with that of normla control subjects in both prenatal and postnatal period. and they showed increased stroke volume and cardiac output but also increase neergy loss, reduced diastolic mechanics in those with systmeic RV. First, the authors work is novel and do demonstrated increased understanding of altered cardiac mechanics by using advance echocardiographic technique. This may help to increase our understanding of the pathophysiology. However, the comparison between the patients and controls is compounded by the fact that the patients had unbalanced ventricles. The right ventricle in the subjects is not only pressured loaded when compared to normal subpulmonary ventricle, but also volumed loaded because the systemic RV has to provide driving force to both pulmonary and systemic circulation, which is unlike in other systemic RV (such as TGA or CCTGA) that the systemic RV only sustains systemic circulation. As such their findings have to be interpreted with caution and could not be applied to TGA or CCTGA, both also having systemic RV before surgical switch operation. And this should be described and addressed in their discussion that they are studying a subset of systemic RV. Reviewer #6: This paper is well-structured, with detailed results, and a complete and comprehensive discussion, also acknowledging the study's limitations. The data presented are original and interesting, and the authors have clearly emphasised the lack of data in this field and the potential benefit and knowledge that their paper could provide. Some paragraphs are challenging for some reader that has no strong familiarity with the algorithm beyond some of the measurements adopted. A more easy explanation of the novel hydrodynamic parameters would enhance the reader's understanding. Especially the image analysis workflow section [130-248] maybe should be simplified and further summarized with the help of more diagrams or figures. The results are well presented with appropriate use of tables and figures to illustrate key findings. Maybe the clinical relevance of the findings should be further stressed. The potential clinical applications of the novel parameters are generic and should be better articulated in the conclusion. Highlighting the clinical implications of these findings more explicitly would strengthen the impact of the results. In summary, the paper is well-written and provides valuable datas. With minor revisions, it would be a fit for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #5: No Reviewer #6: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Fetal and Neonatal Echocardiographic Analysis of Biomechanical Alterations for the Systemic Right Ventricle Heart PONE-D-23-30430R2 Dear Dr. Vlachos, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hany Mahmoud Abo-Haded, MD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-30430R2 PLOS ONE Dear Dr. Vlachos, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Hany Mahmoud Abo-Haded Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .